These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 11956078)
1. Glutathione S-transferase P1 and NADPH quinone oxidoreductase polymorphisms are associated with aberrant promoter methylation of P16(INK4a) and O(6)-methylguanine-DNA methyltransferase in sputum. Gilliland FD; Harms HJ; Crowell RE; Li YF; Willink R; Belinsky SA Cancer Res; 2002 Apr; 62(8):2248-52. PubMed ID: 11956078 [TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099 [TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
4. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Harden SV; Tokumaru Y; Westra WH; Goodman S; Ahrendt SA; Yang SC; Sidransky D Clin Cancer Res; 2003 Apr; 9(4):1370-5. PubMed ID: 12684406 [TBL] [Abstract][Full Text] [Related]
5. [p16 and MGMT gene methylation in sputum cells of uranium workers]. Su SB; Yang LJ; Zhang W; Jin YL; Nie JH; Tong J Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):92-5. PubMed ID: 16600113 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549 [TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
8. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369 [TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584 [TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804 [TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Soria JC; Rodriguez M; Liu DD; Lee JJ; Hong WK; Mao L Cancer Res; 2002 Jan; 62(2):351-5. PubMed ID: 11809677 [TBL] [Abstract][Full Text] [Related]
12. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Fujiwara K; Fujimoto N; Tabata M; Nishii K; Matsuo K; Hotta K; Kozuki T; Aoe M; Kiura K; Ueoka H; Tanimoto M Clin Cancer Res; 2005 Feb; 11(3):1219-25. PubMed ID: 15709192 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Chan EC; Lam SY; Fu KH; Kwong YL Cancer Genet Cytogenet; 2005 Oct; 162(1):10-20. PubMed ID: 16157195 [TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887 [TBL] [Abstract][Full Text] [Related]
16. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Palmisano WA; Divine KK; Saccomanno G; Gilliland FD; Baylin SB; Herman JG; Belinsky SA Cancer Res; 2000 Nov; 60(21):5954-8. PubMed ID: 11085511 [TBL] [Abstract][Full Text] [Related]
17. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302 [TBL] [Abstract][Full Text] [Related]
18. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159 [TBL] [Abstract][Full Text] [Related]
19. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status. Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569 [TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients. Liu Y; Lan Q; Siegfried JM; Luketich JD; Keohavong P Neoplasia; 2006 Jan; 8(1):46-51. PubMed ID: 16533425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]